Sign in
Taking people in United KingdomNo phase

Tests weight loss diet in people with heart failure and obesity

Tests a low calorie diet for weight loss in adults with heart failure and obesity.

Key facts

Who runs it
University of Oxford
Where
Oxford, United KingdomSee the site
Trial code
Registry title
The Effect of Obesity and Weight Loss in Heart Failure With Preserved Ejection Fraction
Status
Recruiting
People taking part
120 people, planned
Started
20 Jan 2023
Expected to end
Dec 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Diet intervention
Record updated
24 April 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with heart failure with preserved ejection fraction who are overweight or obese. It tests whether weight loss with a low calorie diet helps the heart and daily life.

Age
18 to 85 years
Sex
All sexes can join.
Disease stage
Heart failure with preserved ejection fraction (HFpEF), with left ventricular ejection fraction (LVEF) =/> 50%. NYHA class IV cannot join.
Biomarker or test result
Body Mass Index (BMI) approximately =/> 27.5 kg/m^2.

Main reasons for not taking part

  • Contraindications to magnetic resonance imaging
  • NYHA class IV
  • Significant valvular, ischemic, infiltrative or other potentially confounding cardiac disease
  • Pregnancy, planned pregnancy or lactating
  • Any other conditions which may potentially compromise the safety or scientific validity of the study

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Heart failure with preserved ejection fraction (HFpEF)
  • Left ventricular ejection fraction (LVEF) =/> 50%
  • Body Mass Index (BMI) approximately =/> 27.5 kg/m\^2

Who cannot take part

  • Significant valvular, ischemic, infiltrative or other potentially confounding cardiac disease
  • Any other conditions which may potentially compromise the safety or scientific validity of the study
  • Contraindications to magnetic resonance imaging
  • NYHA class IV
  • Pregnancy, planned pregnancy or lactating

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 85 years old?

Where in United Kingdom

  • Oxford Centre for Clinical Magnetic Resonance Research, John Radcliffe HospitalOxford, United KingdomContact: Jiliu Pan, BMBChTaking people

About the trial

What the trial wants to find out

This study looks at the effects of weight loss in people who have heart failure with preserved ejection fraction (HFpEF) and are overweight or obese.

Read full original descriptionShow less

The main questions it aims to answer are whether weight loss in this group of people improves:

1. The heart's shape, how well it pumps blood and how well it uses fuels 2. The person's quality of life and how much they can exercise

Participants will attend 2 study visits, separated by 3-6 months. The intervention period takes place in between the 2 study visits.

Each study visit will involve measurements including:

* Symptom and quality of life questionnaires * Body measurements such as height and weight * Blood tests * Ultrasound scans of the heart (echocardiogram) * Magnetic Resonance Imaging (MRI) scans of the heart * Exercise components during the scans * 6 minute walk test

Participants are randomly allocated (in other words, by lottery) to either 'diet' or 'control' groups. The control group will continue standard care.

The diet group will be enrolled in a weight loss program supervised by the study team. Participants in the diet group will replace their usual meals with meal replacement products specifically designed to deliver a low calorie diet for weight loss. The products will consist of formula soups, shakes and porridges. This diet would last 8 weeks, followed by a guided period of food reintroduction and maintenance.

The 2 groups in the trial

  • DietTreatment being tested

    Diet intervention (in addition to standard clinical care)

    Treatment: Diet intervention

  • ControlNo study treatment, for comparison

    Standard clinical care only

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effects of Obesity and Weight Loss in Heart Failure: Imaging the Obesity Paradox Using Magnetic Resonance Imaging and Spectroscopy - Heart Failure With Preserved Ejection Fraction Substudy
Plain-language title
Tests weight loss diet in people with heart failure and obesityGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT05878912, who can take part
Record updated
24 April 2024